{
    "title": "Pfizer asks for FDA authorization for booster for everyone 18 and up",
    "news": [
        {
            "id": 0,
            "text": "Pfizer-BioNTech asked the Food and Drug Administration on Tuesday for emergency use authorization for its Covid-19 booster shot for everyone ages 18 and up, a ruling the company has been angling for for several months."
        },
        {
            "id": 1,
            "text": "Pfizer\u2019s request will be considered by the FDA, which will make a final decision in the coming weeks."
        },
        {
            "id": 2,
            "text": "It\u2019s unclear whether the agency will ask its independent advisory group, called the Vaccines and Related Biological Products Advisory Committee, to offer guidance."
        },
        {
            "id": 3,
            "text": "Full coverage of the Covid-19 pandemic"
        },
        {
            "id": 4,
            "text": "Pfizer\u2019s booster shot is authorized for certain subsets of adults in the U.S.: people ages 65 and up, people living in long-term care facilities and people ages 18 to 64 at high risk of Covid because of underlying medical conditions or their jobs."
        },
        {
            "id": 5,
            "text": "It is given six months after completion of the initial two-dose vaccination series."
        },
        {
            "id": 6,
            "text": "But those complicated criteria are not what the company initially intended."
        },
        {
            "id": 7,
            "text": "In its first push for a booster, Pfizer asked the FDA to authorize the additional shots for everyone ages 16 and up."
        },
        {
            "id": 8,
            "text": "The FDA advisory panel, however, rejected the request, limiting the shots to certain groups, in part because of safety concerns in younger people."
        },
        {
            "id": 9,
            "text": "Pfizer\u2019s latest request says results from a Phase 3 clinical trial with more than 10,000 participants found that the third dose was safe and effective."
        },
        {
            "id": 10,
            "text": "If the FDA authorizes the booster shot for the younger age group, the Centers for Disease Control and Prevention must officially recommend it before it can be administered."
        },
        {
            "id": 11,
            "text": "Download the NBC News app for full coverage of the Covid-19 pandemic"
        },
        {
            "id": 12,
            "text": "The question of when to lower age requirements for boosters came up in a meeting of the FDA advisory committee last month; no votes were taken on the subject."
        },
        {
            "id": 13,
            "text": "At the time, some committee members signaled openness to revisiting it."
        },
        {
            "id": 14,
            "text": "\u201cThis is a complex topic,\u201d a committee member, Dr. Ofer Levy, the director of the Precision Vaccines Program at Boston Children\u2019s Hospital, said at the time."
        },
        {
            "id": 15,
            "text": "\u201cAnd I think we need to follow the data and keep an open mind, and I\u2019m generally supportive of coming down in age on the boosters, and I look forward to those conversations.\u201d"
        },
        {
            "id": 16,
            "text": "Dr. Peter Chin-Hong, an infectious disease doctor at the University of California, San Francisco, said his thinking on boosters has changed in recent months."
        },
        {
            "id": 17,
            "text": "\u201cI think a lot of people are actually changing their minds a little bit from the initial thought of \u2018no boosters are needed,\u2019\u201d Chin-Hong said."
        },
        {
            "id": 18,
            "text": "The shift came, he said, from personal experience seeing patients with breakthrough cases of Covid and from better data showing the waning effectiveness of the vaccinations over time."
        },
        {
            "id": 19,
            "text": "That the initial vaccinations still hold up against hospitalization and death for younger age groups is reassuring, but protection against infection is important, too, Chin-Hong said."
        },
        {
            "id": 20,
            "text": "\u201cIt is a drag to even get an infection right now, meaning you have to tell everybody you are in contact with, you stay home from work and school,\u201d he said."
        },
        {
            "id": 21,
            "text": "Since Pfizer\u2019s booster was first authorized in late September, more than 14 million people have rolled up their sleeves for the shot in the U.S., according to the CDC."
        },
        {
            "id": 22,
            "text": "Booster shots of the Moderna and Johnson & Johnson vaccines were authorized in October."
        },
        {
            "id": 23,
            "text": "Anyone over 18 who was initially vaccinated with the Johnson & Johnson vaccine is eligible for a booster."
        },
        {
            "id": 24,
            "text": "Eligibility rules for a booster after having been vaccinated with the Moderna vaccine mirror the Pfizer criteria."
        }
    ],
    "entities": [
        {
            "text": "Pfizer",
            "id": "Eentity#0",
            "entityType": "Organization"
        },
        {
            "text": "Food and Drug Administration",
            "id": "Eentity#1",
            "entityType": "Organization"
        },
        {
            "text": "Younger People",
            "id": "Eentity#2",
            "entityType": "People"
        },
        {
            "text": "Ofer Levy",
            "id": "Eentity#3",
            "entityType": "People"
        }
    ],
    "annotations": [
        {
            "e_id": "EventMO#0",
            "para": 0,
            "agent": "Pfizer",
            "patient": "Food and Drug Administration",
            "event": "asked the Food and Drug Administration on Tuesday for emergency use authorization",
            "event_trigger": "authorization",
            "agent2": "",
            "patient2": "",
            "agent3": "",
            "patient3": "",
            "morality": "Authority",
            "status": "Actual",
            "morality2": "",
            "morality3": ""
        },
        {
            "e_id": "EventMO#1",
            "para": 7,
            "agent": "Pfizer",
            "patient": "Food and Drug Administration",
            "event": "asked the FDA to authorize",
            "event_trigger": "authorize",
            "agent2": "",
            "patient2": "",
            "agent3": "",
            "patient3": "",
            "morality": "Authority",
            "status": "Actual",
            "morality2": "",
            "morality3": ""
        },
        {
            "e_id": "EventMO#3",
            "para": 8,
            "agent": "Food and Drug Administration",
            "patient": "Younger People",
            "event": "safety concerns",
            "event_trigger": "concerns",
            "agent2": "",
            "patient2": "",
            "agent3": "",
            "patient3": "",
            "morality": "Care",
            "status": "Actual",
            "morality2": "",
            "morality3": ""
        },
        {
            "e_id": "EventMO#4",
            "para": 15,
            "agent": "Ofer Levy",
            "patient": "Pfizer",
            "event": "supportive of coming down in age on the boosters",
            "event_trigger": "supportive",
            "agent2": "",
            "patient2": "",
            "agent3": "",
            "patient3": "",
            "morality": "Care",
            "status": "Actual",
            "morality2": "",
            "morality3": ""
        }
    ],
    "entities_count": 4,
    "events_count": 4,
    "sentence_count": 25,
    "word_count": 570,
    "article_ideology_1": "Slightly Liberal",
    "article_ideology_2": "Slightly Liberal",
    "DOCNAME": "TRIPLET_1229_DOCUMENT_0"
}